ESMO 2019 | R/R DLBCL challanges: novel therapeutics

Jarrod Longcor

Jarrod Longcor, MA, MBA, Cellectar Biosciences, Madison, WI, discusses the challenges of designing therapies for R/R diffuse large B-cell lymphoma (DLBCL) and these may be overcome. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  
Similar topics